| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |